Published in Proteomics Clin Appl on December 01, 2010
Biomarkers for severity of neonatal hypoxic-ischemic encephalopathy and outcomes in newborns receiving hypothermia therapy. J Pediatr (2013) 1.90
Development of biomarkers to optimize pediatric patient management: what makes children different? Biomark Med (2011) 0.81
Label-free mass spectrometric analysis reveals complex changes in the brain proteome from the mdx-4cv mouse model of Duchenne muscular dystrophy. Clin Proteomics (2015) 0.78
Clinical significance of serum biomarkers in pediatric solid mediastinal and abdominal tumors. Int J Mol Sci (2012) 0.77
The proteomics of lung injury in childhood: challenges and opportunities. Clin Proteomics (2016) 0.76
Urinary biomarkers and acute kidney injury in children: the long road to clinical application. Pediatr Nephrol (2013) 0.75
Proteomic and biomarker studies and neurological complications of pediatric sickle cell disease. Proteomics Clin Appl (2014) 0.75
Tricuspid annular plane systolic excursion and right ventricular ejection fraction in pediatric and adolescent patients with tetralogy of Fallot, patients with atrial septal defect, and age-matched normal subjects. Clin Res Cardiol (2010) 2.26
Right ventricular function in infants, children and adolescents: reference values of the tricuspid annular plane systolic excursion (TAPSE) in 640 healthy patients and calculation of z score values. J Am Soc Echocardiogr (2009) 1.59
Percutaneous closure of patent ductus arteriosus: a multiinstitutional registry comparing multiple devices. Catheter Cardiovasc Interv (2010) 1.36
Glial fibrillary acidic protein as a biomarker for neonatal hypoxic-ischemic encephalopathy treated with whole-body cooling. Am J Obstet Gynecol (2011) 1.31
Expression of hepatoma-derived growth factor is a strong prognostic predictor for patients with early-stage non-small-cell lung cancer. J Clin Oncol (2004) 1.18
Hepatoma-derived growth factor induces tumorigenesis in vivo through both direct angiogenic activity and induction of vascular endothelial growth factor. Cancer Sci (2003) 1.11
Insights into developmental mechanisms and cancers in the mammalian intestine derived from serial analysis of gene expression and study of the hepatoma-derived growth factor (HDGF). Development (2004) 1.11
Assessment of pulmonary hypertension in the pediatric catheterization laboratory: current insights from the Magic registry. Catheter Cardiovasc Interv (2010) 1.09
Hepatoma-derived growth factor binds DNA through the N-terminal PWWP domain. BMC Mol Biol (2007) 1.04
Databases for assessing the outcomes of the treatment of patients with congenital and paediatric cardiac disease--the perspective of cardiology. Cardiol Young (2008) 1.03
Functional proteomic analysis of melanoma progression. Cancer Res (2003) 1.02
Frontiers in pulmonary hypertension in infants and children with bronchopulmonary dysplasia. Pediatr Pulmonol (2012) 1.01
The isolation of novel mesenchymal stromal cell chemotactic factors from the conditioned medium of tumor cells. Exp Cell Res (2008) 0.91
Systolic right ventricular function in pediatric and adolescent patients with tetralogy of Fallot: echocardiography versus magnetic resonance imaging. J Am Soc Echocardiogr (2010) 0.90
Plasma glial fibrillary acidic protein levels in a child with sickle cell disease and stroke. Acta Haematol (2010) 0.89
ACC/AHA/SCAI 2014 health policy statement on structured reporting for the cardiac catheterization laboratory: a report of the American College of Cardiology Clinical Quality Committee. J Am Coll Cardiol (2014) 0.89
Hepatoma-derived growth factor is highly expressed in developing liver and promotes fetal hepatocyte proliferation. Hepatology (2002) 0.89
Hepatoma-derived growth factor is expressed after vascular injury in the rat and stimulates smooth muscle cell migration. Pediatr Res (2006) 0.88
Glial fibrillary acidic protein as a biomarker for periventricular white matter injury. Am J Obstet Gynecol (2013) 0.87
Hepatoma-derived growth factor represses SET and MYND domain containing 1 gene expression through interaction with C-terminal binding protein. J Mol Biol (2009) 0.86
Improved protein extraction and protein identification from archival formalin-fixed paraffin-embedded human aortas. Proteomics Clin Appl (2013) 0.84
Report from the international society for nomenclature of paediatric and congenital heart disease: creation of a visual encyclopedia illustrating the terms and definitions of the international pediatric and congenital cardiac code. World J Pediatr Congenit Heart Surg (2010) 0.81
Plasma proteomics of differential outcome to long-term therapy in children with idiopathic pulmonary arterial hypertension. Proteomics Clin Appl (2012) 0.81
Plasma Biomarkers of Brain Injury as Diagnostic Tools and Outcome Predictors After Extracorporeal Membrane Oxygenation. Crit Care Med (2015) 0.81
Proteomic and other mass spectrometry based "omics" biomarker discovery and validation in pediatric venous thromboembolism and arterial ischemic stroke: current state, unmet needs, and future directions. Proteomics Clin Appl (2014) 0.81
Identification and characterization of citrulline-modified brain proteins by combining HCD and CID fragmentation. Proteomics (2013) 0.80
Device closure of secundum atrial septal defects in infants weighing less than 8 kg. Pediatr Cardiol (2014) 0.79
Juxtamembrane localization of the protein phosphatase-1 inhibitor protein PHI-1 in smooth muscle cells. Histochem Cell Biol (2004) 0.79
The untapped potential of proteomic analysis in pediatric pulmonary hypertension. Proteomics Clin Appl (2014) 0.77
Detection of neurologic injury using vascular reactivity monitoring and glial fibrillary acidic protein. Pediatrics (2013) 0.76
Development and clinical evaluation of a multi-purpose mAb and a sandwich ELISA test for hepatoma-derived growth factor in lung cancer patients. J Immunol Methods (2010) 0.76
ACC/AHA/SCAI 2014 health policy statement on structured reporting for the cardiac catheterization laboratory: a report of the American College of Cardiology Clinical Quality Committee. Circulation (2014) 0.75
Proteomic and biomarker studies and neurological complications of pediatric sickle cell disease. Proteomics Clin Appl (2014) 0.75
2017 AHA/ACC Key Data Elements and Definitions for Ambulatory Electronic Health Records in Pediatric and Congenital Cardiology: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards. Circ Cardiovasc Qual Outcomes (2017) 0.75
2017 AHA/ACC Key Data Elements and Definitions for Ambulatory Electronic Health Records in Pediatric and Congenital Cardiology: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards. J Am Coll Cardiol (2017) 0.75